These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6088161)

  • 1. [Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
    Capurso L; Tarquini M; Luzietti L; Palomba M; Bazuro G; Papi C; Fracasso P; Koch M
    Clin Ter; 1984 May; 109(4):335-44. PubMed ID: 6088161
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
    Chearanai O; Kachintorn U; Plengvanit U
    J Med Assoc Thai; 1987 Apr; 70(4):176-80. PubMed ID: 3612003
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I; Worsley BW; O'Connor HJ; Axon AT
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
    Bergoz R
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1024-5. PubMed ID: 4048901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the efficacy of De-Nol and ranitidine in treating duodenal ulcer].
    Oproiu A; Pospai D; Cociaşu S; Oproiu C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(4):375-84. PubMed ID: 2905519
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine in the treatment of peptic ulcer.
    Makalinao AU; Zaño FM
    Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K; Nowak A; Marlicz K; Depczyńska A; Dzieniszewski J; Milewski B; Gabryelewicz A; Kosidło S
    Pol Tyg Lek; 1984 Nov; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract]   [Full Text] [Related]  

  • 10. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M; Lee S; Tasman-Jones C; Nicholson G
    N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucus secretion in gastric ulcer patients treated with tripotassium dicitrato bismuthate (De-Nol).
    Hollanders D; Morrissey SM; Mehta J
    Br J Clin Pract; 1983 Mar; 37(3):112-4. PubMed ID: 6882629
    [No Abstract]   [Full Text] [Related]  

  • 12. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
    Hamilton I; O'Connor HJ; Wood NC; Bradbury I; Axon AT
    Gut; 1986 Jan; 27(1):106-10. PubMed ID: 3512382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Open study of ranitidine in short-term treatment of gastroduodenal ulcer].
    Varas MJ; Oliva I
    Rev Esp Enferm Apar Dig; 1984 Apr; 65(4):349-52. PubMed ID: 6330807
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
    Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
    Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF; Frazer NM; Keene ON; Smith JT
    Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
    Patty I; Deák G; Jávor T; Mózsik G; Nagy L; Tárnok F
    Int J Tissue React; 1983; 5(4):397-401. PubMed ID: 6368445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of sucralfate in the treatment of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1989 Jan; 67(1):98-102. PubMed ID: 2716262
    [No Abstract]   [Full Text] [Related]  

  • 18. Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication?
    Bell GD; Powell K; Burridge SM; Harrison G; Weil J; Gant PW; Jones PH; Trowell JE
    Aliment Pharmacol Ther; 1992 Jun; 6(3):327-33. PubMed ID: 1600049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the efficacy of ranitidine, cimetidine (Asiloc), De-Nol and spirulina in the treatment of gastric and duodenal ulcer].
    Fica V; Andronescu D; Olteanu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(1):21-35. PubMed ID: 2884709
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of tri-potassium di-citrato bismuthate (TDB) with ranitidine in healing and relapse of gastric ulcer.
    Cipollini F; Altilia F
    Br J Clin Pract; 1987 Apr; 41(4):707-9. PubMed ID: 3689651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.